المؤلفون: Milhem, MM, Vanderwalde, AM, Bowles, TL, Sacco, JJ, Niu, J, Tsai, KK, Chesney, JA, Chmielowski, B, Samson, A, Rhodes, TD, In, GK, Pavlick, AC, Wise-Draper, TM, Sanmamed, MF, Bommareddy, P, Zhu, J, Coffin, RS, Harrington, KJ, Middleton, MR

Relation: Milhem, MM, Vanderwalde, AM, Bowles, TL et al. (16 more authors) (2022) Updated results from the skin cancer cohorts from an ongoing phase 1/2 multicohort study of RP1, an enhanced potency oncolytic HSV, combined with nivolumab (IGNYTE). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Illinois.

الاتاحة: https://eprints.whiterose.ac.uk/193483/